<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                                                                                                                                      MBoC&#226;&#8364;&#8218; |&#226;&#8364;&#8218; ARTICLE <br />  <br />  <br />  <br />  E3 ubiquitin ligase mind bomb 1 <br /> ubiquitinates promotes degradation survival motor neuron protein <br /> Deborah Y. Kwona,b, Maria Dimitriadib, Barbara Terzica, Casey Cablea, Anne C. Hartb, Ajay Chitnisc, <br /> Kenneth H. Fischbecka, Barrington G. Burnetta  Neurogenetics Branch, National Institute Neurological Disorders Stroke, National Institutes Health, <br /> Bethesda, MD 20892; bDepartment Neuroscience, Brown University, Providence, RI 02912; cProgram Genomics Development, Eunice Kennedy Shriver National Institute Child Health Human Development, National <br /> Institutes Health, Bethesda, MD 20892 <br />  <br />  <br />  <br />  <br /> ABSTRACT&#226;&#8364;&#8218; Spinal muscular atrophy inherited motor neuron disease results                                  Monitoring Editor <br /> deficiency survival motor neuron (SMN) protein. SMN ubiquitinated degraded                                 William P. Tansey <br />                                                                                                                             Vanderbilt University ubiquitin proteasome (UPS). previously shown proteasome <br /> inhibition increases SMN protein levels, improves motor function, reduces spinal cord,                                  Received: Jan 18, 2013 <br /> muscle, neuromuscular junction pathology spinal muscular atrophy (SMA) mice. Spe-                                    Revised: Apr 8, 2013 <br /> cific targets UPS efficacious toxic. study,                            Accepted: Apr 16, 2013 <br /> E3 ubiquitin ligase, mind bomb 1 (Mib1), interacts ubiquitinates SMN facilitates degradation. Knocking Mib1 levels increases SMN protein levels cultured cells.  knocking Mib1 orthologue improves neuromuscular function Caenorhabditis <br /> elegans deficient SMN. findings demonstrate Mib1 ubiquitinates catalyzes degradation SMN, represents novel therapeutic target SMA. <br />  <br />  <br />  <br /> INTRODUCTION <br /> Spinal muscular atrophy (SMA) autosomal recessive neurologi-                     rapidly degraded (Coovert et&#194;&#160; al., 1997; Lorson et&#194;&#160; al., 1999; <br /> cal disorder characterized loss lower motor neurons, leading                     Lorson Androphy, 2000; Monani et&#194;&#160; al., 1999; Burnett et&#194;&#160; al., weakness skeletal muscle atrophy, leading                  2009). Human SMN2 transgenic mice mitigates severity genetic causes infant death. 90% SMA results                      SMA disease phenotype mouse smn-null background, deletion survival motor neuron (SMN1) gene, patients                   gene dosage effect (Hsieh-Li et&#194;&#160;al., 2000). Patients mild SMA <br /> retaining copy homologue SMN2 (Lefebvre et&#194;&#160;al.,                    phenotypes SMN2 copies, indi- <br /> 1995). SMN1 produces predominantly length SMN pro-                          viduals SMN2 genes pheno- <br /> tein, SMN2 contains translationally silent C T transition                  typically normal (Lefebvre et&#194;&#160;al., 1995; McAndrew et&#194;&#160;al., 1997; Prior <br /> exon 7, causing exon skipped mRNA                             et&#194;&#160;al., 2004). <br /> splicing producing truncated protein (SMN&#206;&#8221;7) unstable                        SMN degraded ubiquitin proteasome                                                                                        (UPS; Chang et&#194;&#160;al., 2004; Burnett et&#194;&#160;al., 2009; Kwon et&#194;&#160;al., 2011). <br />                                                                                         proteins destined degradation tagged link- <br />                                                                                        age ubiquitin action enzymes: E1 (ubiquitin- article published online ahead print MBoC Press (http://www <br /> .molbiolcell.org/cgi/doi/10.1091/mbc.E13-01-0042) April 24, 2013.                   activating), E2 (ubiquitin-conjugating), E3 (ubiquitin ligase) authors declare conflict                             (Petroski, 2008). E3 ligases confer substrate specificity Address correspondence  Barrington G. Burnett (burnettb@ninds.nih.gov).             process considered candidates targeted <br /> Abbreviations used: Mib1, mind bomb 1; NMJ, neuromuscular junction; RING,              inhibition protein degradation. <br /> really interesting new gene; SMA, spinal muscular atrophy; SMN, survival motor <br /> neuron; UPS, ubiquitin proteasome                                                   shown SMN protein levels increased cell <br /> &#194;&#169; 2013 Kwon et&#194;&#160;al. article distributed American Society Cell Bi-    culture animal models inhibition proteasome (Burnett <br /> ology license author(s). months publication available   et&#194;&#160;al., 2009; Kwon et&#194;&#160;al., 2011). protein degradation public Attribution&#226;&#8364;&#8220;Noncommercial&#226;&#8364;&#8220;Share Alike 3.0 Unported <br /> Creative Commons License (http://creativecommons.org/licenses nc-sa/3.0). <br />                                                                                        UPS essential process cellular homeostasis general inhi- <br /> &#226;&#8364;&#339;ASCB&#194;&#174;,&#226;&#8364;?  American Society Cell Biology&#194;&#174;,&#226;&#8364;? &#226;&#8364;&#339;Molecular Biology           bition undesired effects, sought identify char- Cell&#194;&#174;&#226;&#8364;? registered trademarks American Society Cell Biology.          acterize E3 ligase(s) responsible specifically targeting SMN <br />  <br />  <br /> Volume 24&#226;&#8364;&#402; June 15, 2013	                                                                                                                             1863&#226;&#8364;&#402; <br />  degradation. chose evaluate mind bomb 1 (Mib1)              uitinated proteins, consistent results cultured cells (Figure <br /> candidate, based role inhibiting outgrowth neurites       1C). Given Mib1 ubiquitinates SMN, sought quantify cultured neurons (Choe et&#194;&#160;al., 2007). Loss Drosophila melano-        effect Mib1 SMN protein turnover. performed pulse&#226;&#8364;&#8220; <br /> gaster Mib1 increases number synaptic boutons neuromus-          chase analysis using HEK-293T cells transfected wild-type <br /> cular junctions (NMJs), producing synaptic overgrowth, reduc-        Mib1-myc active-site mutant, Mib1-C1009S-myc, deter- <br /> tion SMN reduces number NMJ boutons D. melanogaster           E3 ligase activity Mib1 alters SMN protein half- results aberrantly truncated motor neurons Danio rerio           life. overexpressing wild-type Mib1 decreased (McWhorter et&#194;&#160; al., 2003; Choe et&#194;&#160; al., 2007; Chang et&#194;&#160; al., 2008).        half-life newly synthesized radiolabeled SMN half, &#226;&#710;&#188;4 Mib1 multidomain enzyme carboxyl-terminal really           2 h, compared active-site Mib1 mutant (Figure 1D). addi- <br /> interesting new gene (RING) finger domains (Jin et&#194;&#160;al., 2002; Itoh         tion, overexpressing Mib1 NSC34 cells reduced steady-state <br /> et&#194;&#160;al., 2003; Yoo et&#194;&#160;al., 2006; Zhang et&#194;&#160;al., 2007). best-character-   levels SMN protein, effect blocked protea- <br /> ized role activating Delta-Notch signaling pathway,        inhibitor bortezomib (Figure 2A), indicating Mib1 targets <br /> controls differentiation regulating cell&#226;&#8364;&#8220;cell communication (Itoh       SMN proteasomal degradation. <br /> et&#194;&#160;al., 2003; Chen Casey Corliss, 2004; Barsi et&#194;&#160;al., 2005; Koo            SMN complex assembled cytoplasm et&#194;&#160; al., 2005a; Lai et&#194;&#160; al., 2005). functions Mib1      imported nucleus, localizes Cajal bodies emerged. Mib1 identified postsynaptic densities,            gems. number SMN-positive nuclear bodies shown function binding partner            used measure evaluating changes functional SMN protein <br /> CDK5 complex regulating morphogenesis postmitotic neurons            levels (Coovert et&#194;&#160;al., 1997; Jarecki et&#194;&#160;al., 2005; Wolstencroft et&#194;&#160;al., <br /> (Choe et&#194;&#160; al., 2007) regulating apoptosis promoting          2005). counted number SMN-positive nuclear puncta proteasomal degradation anti-apoptotic factor death-associ-         nucleus assessed fluorescence intensity HeLa cells  <br /> ated protein kinase (DAPK; Jin et&#194;&#160;al., 2002). Recently overexpres-         expressing wild-type Mib1 mutant Mib1-C1009S. sion Mib1 shown promote ubiquitination receptor-          number intensity SMN-positive bodies significantly <br /> like tyrosine kinase (RYK), reducing steady-state levels        reduced cells overexpressing wild-type Mib1 compared  <br /> plasma membrane (Berndt et&#194;&#160;al., 2011).                                     transfected cells (Alexa Fluor 488&#226;&#8364;&#8220;negative) express- <br />     study, SMN interacts Mib1           ing Mib1-C1009S (p &lt; 0.0001, Figure 2B).  data <br /> overexpression Mib1 cultured cells increases SMN ubiquitina-         demonstrate Mib1 determines SMN protein levels promot- <br /> tion degradation. Importantly, Mib1 knockdown results            ing ubiquitination subsequent degradation. <br /> creased SMN levels cultured cells ameliorates neuromus- <br /> cular pharyngeal pumping defect Caenorhabditis elegans                  Reducing Mib1 expression increases SMN protein levels <br /> deficient SMN, indicating physiological role Mib1 modu-        Mib1 overexpression decreased SMN levels inves- <br /> lating SMN.                                                                tigated decreasing Mib1 increases SMN levels. trans- <br />                                                                            fected HEK-293T cells Mib1 small interfering RNA (siRNA) RESULTS                                                                    scrambled control, confirmed RT-PCR Mib1 levels <br /> Mib1 increases SMN ubiquitination protein turnover                     reduced half 72 h transfection Mib1 <br /> E3 ligases promote protein degradation catalyzing transfer       siRNA (Figure 3A). Importantly, SMN protein levels significantly <br /> ubiquitin molecules E2 enzyme substrate proteins.         increased Mib1 knocked (p &lt; 0.001, Figure 3A). determine Mib1 ubiquitinates SMN, cotransfected             previously reported microRNA miR-137 targets <br /> motor neuron&#226;&#8364;&#8220;derived hybrid cell line, NSC34, hemagglutinin           Mib1 mRNA regulates protein expression (Smrt et&#194;&#160;al., 2010). <br /> (HA)-tagged ubiquitin length selected domains myc-          sought determine overexpressing miR-137 af- <br /> tagged Mib1. cells lysed buffer containing ubiq-          fects SMN protein levels. confirmed transfection cells <br /> uitin aldehyde inhibit deubiquitination immunoprecipitated          miR-137 decreased Mib1 mRNA protein levels (Figure 3B), antibody SMN. ensure ubiquitin-positive             SMN levels increased cells transfected <br /> bands Western blot ubiquitinated SMN ubiq-             miR-137 compared scrambled microRNA control (Figure <br /> uitinated proteins associated SMN, disassociated SMN          3B). Importantly, confirmed short hairpin RNA (shRNA) binding partners immunoprecipitation denaturing              knockdown Mib1 increases SMN protein levels SMA patient&#226;&#8364;&#8220; 1% SDS, followed renaturation 4.5% Triton X-100.           derived fibroblasts (Figure 3C). SMN transcript levels  conditions sufficient dissociate SMN known              changed siRNA Mib1 miR-137 (Figure 3D).  using <br /> binding partners (Supplemental Figure S1). Immunoblots immu-            independent techniques cell lines shown <br /> noprecipitated SMN probed anti-HA antibody detect             reducing Mib1 expression results increased SMN protein <br /> ubiquitinated SMN. ubiquitination endogenous SMN,                levels. <br /> indicated high-molecular-weight, ubiquitin-positive smear, increased cells expressing length, truncated active-    Interaction Mib1 SMN mediated site mutant forms Mib1 (Figure 1, B). contrast, overex-        N-terminal domain Mib1 segment SMN <br /> pressing E3 ligase parkin did increase SMN ubiquitination,         encoded exon 6 <br /> ruling possibility overexpressing E3 ligase         investigated Mib1 interacts SMN. Using indiscriminately increase SMN ubiquitination (Figure S2).          monoclonal antibody SMN, endogenous Mib1 <br /> performed vitro ubiquitination assay determine            coimmunoprecipitated endogenous SMN (Figure 4A), indicat- <br /> Mib1 directly ubiquitinates SMN. Purified recombinant Mib1             ing proteins associate. interaction detectable  <br /> SMN proteins incubated reaction buffer containing ubiq-            tween SMN Mib2, homologue Mib1 (Koo et&#194;&#160; al., 2005b) <br /> uitin, ubiquitin-activating enzyme (E1), ubiquitin-conjugating     similar structural domain organization (Figure 4B), demon- <br /> enzyme (E2) UBCH5b. Mib1 ubiquitinates SMN cell-free sys-          strating specificity interaction Mib1 SMN. tem, seen Western blots probed antibody polyubiq-         characterize interaction Mib1 SMN,  <br />  <br /> 1864&#226;&#8364;&#402; |&#226;&#8364;&#402; D. Y. Kwon et al.	                                                                                             Molecular Biology Cell <br />  FIGURE 1:&#226;&#8364;&#8218;   NSC-34 cells transfected 2 &#206;&#188;g Mib1 1 &#206;&#188;g HA-Ub cDNAs. cells harvested 48 h <br /> later, endogenous SMN immunoprecipitated. Immunoprecipitated proteins resolved SDS&#226;&#8364;&#8220;PAGE, proteins analyzed Western blotting. blots probed HA antibody detect ubiquitinated <br /> SMN. (B) Schematic representation Mib1 protein domains. (C) Cell-free SMN ubiquitination assay. Recombinant SMN incubated E1 E2 (UBCH5B) enzymes Mib1 ubiquitin 1 h 37&#194;&#176;C. Western blots probed anti-polyubiquitin antibody (FK1). (D) Pulse&#226;&#8364;&#8220;chase analysis endogenous SMN presence 2 &#206;&#188;g Mib1-myc Mib1-C1009S-myc. data represent mean &#194;&#177; SEM independent experiments. <br />  <br />  <br /> used purified recombinant Mib1 pull assays purified        tion mutant, exception SMN&#206;&#8221;6, coimmunoprecipitated <br /> <span id='am-6' about='obo:IMR_0100173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001700'><span id='am-7' property="rdfs:label" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-8' property="rdfs:label" content="glutathione" datatype="xsd:string"></span><span id='am-9' property="obo:IAO_0000115" content="A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides." datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="L-Glutathione" datatype="xsd:string"></span><span id='am-11' property="rdfs:label" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasExactSynonym" content="5-L-Glutamyl-L-cysteinylglycine" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00051" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasExactSynonym" content="L-Glutathione" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:id" content="IMR:0100173" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="Reduced glutathione" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>glutathione</span> S-transferase (GST)-SMN GST          Mib1, indicating SMN exon 6 required interac- <br /> GST-SMN GST pulled Mib1 (Figure 4C),             tion Mib1 (Figure 4E).  deletion firming direct interaction SMN Mib1 showing           SMN exon 6 disrupts binding Mib1 markedly  factors, including members SMN complex,       duced ubiquitination Mib1 (Figure 4F). domain <br /> required interaction.                                          encoded exon 6 mediates SMN oligomerization, examined <br />     asked domains Mib1 mediate interaction         SMN oligomerization required Mib1 interact with SMN. Using constructs containing various regions Mib1       SMN. Mib1 coimmunoprecipitated wild-type <br /> gene, performed coimmunoprecipitation assays map           SMN patient-derived SMN mutants SMN-G279V <br /> mains Mib1 required SMN binding. N-terminal         SMN-Y272C, efficiently self-associate oli- <br /> gion Mib1 (m132-myc) coimmunoprecipitated SMN,              gomerize (Figure 4G). SMN oligomerization required structs containing middle ankyrin repeat C-terminal RING        Mib1 association. <br /> domain showed weak interaction (Figure 4D). Additionally,             sought determine Mib1 contributes  C-terminal active-site mutation C1009S effect SMN         stability SMN&#206;&#8221;7. overexpressing Mib1 resulted <br /> binding (Figure 4D). map regions SMN mediate bind-       greater ubiquitination SMN&#206;&#8221;7 length SMN, ing Mib1, cotransfected FLAG-tagged Mib1 construct            knocking Mib1 increased SMN&#206;&#8221;7 stability (Figure 5, constructs expressing length SMN SMN lacking        B). data suggest instability SMN&#206;&#8221;7 seven translated exons. length SMN dele-      ubiquitination Mib1. <br />  <br />  <br /> Volume 24&#226;&#8364;&#402; June 15, 2013	                                                                          Mib1 targets SMN degradation&#226;&#8364;&#402; |&#226;&#8364;&#402; 1865&#226;&#8364;&#402; <br />                                                                                                     interference (RNAi) feeding <br />                                                                                                    (Timmons  1998; Timmons et&#194;&#160; al., <br />                                                                                                    2001). Knocking Mib-1 C. elegans <br />                                                                                                    orthologue increased pharyngeal <br />                                                                                                    pumping rates smn-1&#226;&#8364;&#8220;deficient animals, <br />                                                                                                    did reach statistical significance <br />                                                                                                    (p = 0.06, Figure S3). RNAi feeding                                                                                                    generally effective neurons                                                                                                    tissues (Kamath et&#194;&#160;al., 2001; Timmons <br />                                                                                                    et&#194;&#160; al., 2001; Rual et&#194;&#160; al., 2004). circum- <br />                                                                                                    vent difficulty, increased neuronal <br />                                                                                                    sensitivity RNAi feeding ectopic neu- <br />                                                                                                    ronal expression SID-1 double- <br />                                                                                                    stranded RNA channel smn-1 animals <br />                                                                                                    (Calixto et&#194;&#160;al., 2010). sensitized  <br />                                                                                                    ground, mib-1 RNAi significantly amelio- <br />                                                                                                    rated smn-1 pharyngeal pumping  <br />                                                                                                    fects (Figure 6A; p = 0.04), suggesting                                                                                                    MIB-1 conserved cross-species modifier <br />                                                                                                    SMN loss function defects.                                                                                                    Mib1 plays important role Notch func- <br />                                                                                                    tion (Itoh et&#194;&#160; al., 2003; Lai et&#194;&#160; al., 2005; Le <br />                                                                                                    Borgne et&#194;&#160;al., 2005), examined                                                                                                    MIB-1 impact perturbations <br />                                                                                                    Notch signaling. Loss Notch coli- <br />                                                                                                    gand function (Komatsu et&#194;&#160;al., 2008; Singh <br />                                                                                                    et&#194;&#160; al., 2011) smn-1 mutants did                                                                                                    ameliorate pharyngeal pumping defect <br />                                                                                                    smn-1(ok355);osm-11(rt142) animals <br />                                                                                                    (Figure 6B). rule SMN- <br />                                                                                                    independent effects, data suggest <br />                                                                                                    MIB-1 directly impacts SMN-1 function <br />                                                                                                    independent Notch signaling. <br />  <br />                                                                                                    DISCUSSION <br />                                                                                                     study, provide evidence <br />                                                                                                     E3 ligase Mib1 ubiquitinates FIGURE 2:&#226;&#8364;&#8218; Effects Mib1 overexpression SMN protein levels gem number.                     catalyzes SMN protein degradation.   HEK-293T cells transfected 1 2 &#206;&#188;g Mib1-myc cDNA. 24 h              effects associated changes transfection, cells treated vehicle (water) 1 &#206;&#188;M bortezomib harvested 6 h SMN mRNA expression ob- <br /> later. Cell lysates resolved SDS&#226;&#8364;&#8220;PAGE, densitometry resulting bands          served ligase-defective point mutant <br /> performed using ImageJ software (National Institutes Health). SMN protein levels                                                                                                     Mib1 expressed. Knocking Mib1 <br /> corrected based actin values. data represent mean &#194;&#177; SEM independent <br />                                                                                                     increases SMN protein levels cultured <br /> experiments. *, p &lt; 0.05. (B) Overexpression Mib1 decreases gem number intensity cultured cells. HeLa cells transfected Mib1-myc Mib-C1009S-myc 24 h. cells cells partially rescues neuromuscular fixed stained antibodies SMN myc appropriate Alexa Fluor               defect SMN deficiency C. elegans. <br /> secondary antibodies visualization microscopy. number intensity nuclear gems data indicate Mib1 reduces SMN quantitated using Nikon NIS Elements software. 300 cells counted        protein stability targeting degrada- <br /> transfection condition. data represent mean &#194;&#177; SEM independent experiments.            tion proteasome represents ***, p &lt; 0.001.                                                                                     new modifier SMA phenotype. <br />                                                                                                         inverse correlation SMN2 <br /> Loss C. elegans orthologue mib-1 ameliorates                     copy number SMA severity indicates increasing SMN pro- <br /> neuromuscular defects caused smn-1 loss function                      tein levels ameliorate disease phenotype. Mechanisms Potential cross-species conservation SMN-MIB1 interaction            increase SMN protein levels actively pursued thera- examined C. elegans. C. elegans genome single              peutic options SMA. Inhibiting degradation SMN orthologue SMN, smn-1. Homozygous smn-1 loss function                 way increase steady-state level. Inhibiting proteasome  <br /> causes developmental delay, impaired locomotion, reduced pha-               creases SMN levels cultured cells SMA model mice (Kwon <br /> ryngeal pumping, larval lethality (Briese et&#194;&#160;al., 2009; Dimitriadi      et&#194;&#160;al., 2011), ameliorates disease phenotype. Identifying <br /> et&#194;&#160;al., 2010). complete loss SMN function causes le-            enzymes specifically target SMN degradation thality, smn-1 animals survive days partial          provide new therapeutic targets. overexpression <br /> maternal rescue. C. elegans orthologue human MIB1             Mib1 increases ubiquitination SMN, indicated increased <br /> gene mib-1 (Berndt et&#194;&#160; al., 2011). assess genetic interactions,          ubiquitin&#226;&#8364;&#8220;SMN conjugates. overexpressed Mib1 ac- decreased Mib-1 levels smn-1&#226;&#8364;&#8220;deficient animals RNA                 celerates rate SMN degradation, knockdown Mib1 <br />  <br />  <br /> 1866&#226;&#8364;&#402; |&#226;&#8364;&#402; D. Y. Kwon et al.	                                                                                           Molecular Biology Cell <br />                                                                                                       ubiquitinates SMN&#206;&#8221;7 greater extent <br />                                                                                                      length SMN. propose                                                                                                      increased Mib1-mediated ubiquitination                                                                                                      SMN&#206;&#8221;7 account                                                                                                      relative instability SMN&#206;&#8221;7 protein. <br />                                                                                                      Consistent  reducing Mib1 levels <br />                                                                                                      results increased stability SMN&#206;&#8221;7 <br />                                                                                                      protein. <br />                                                                                                          interaction SMN <br />                                                                                                      Mib1 likely mediated domain <br />                                                                                                      encoded exon 6. Missense mutations                                                                                                      exon 6 deletion exon 7 disrupt SMN&#226;&#8364;&#8482;s <br />                                                                                                      ability oligomerize (Lorson et&#194;&#160; al., 1998; <br />                                                                                                      Pellizzoni et&#194;&#160;al., 1999; Zhang et&#194;&#160;al., 2003; Le <br />                                                                                                      et&#194;&#160; al., 2005), resulting severe SMA;                                                                                                      SMN fails oligomer- <br />                                                                                                      ize rapidly degraded (Burnett et&#194;&#160;al., 2009). <br />                                                                                                      mutation SMN exon 6 disrupts oli- <br />                                                                                                      gomerization (Y272C) destabilizes                                                                                                      SMN protein, cells patient                                                                                                      mutation similar SMN levels                                                                                                      homozygous deletion SMN1 <br />                                                                                                      (Lefebvre et&#194;&#160;al., 1997). possibility                                                                                                      Mib1 interacts SMN                                                                                                      oligomerized, exon 6 mediates SMN <br />                                                                                                      oligomerization.  likely <br />                                                                                                      Mib1 interacts SMN                                                                                                      patient-derived mutations G279V                                                                                                      Y272C, efficiently oligomerize <br />                                                                                                      (Figure 4G). likely                                                                                                      inability SMN oligomerize increases <br />                                                                                                      likelihood binding Mib1.                                                                                                      exon 6 domain mediates SMN self-asso- <br />                                                                                                      ciation (Lorson et&#194;&#160;al., 1998), domain                                                                                                      available interaction Mib1 <br />                                                                                                      SMN oligomerizes complex. <br />                                                                                                      explain increased stability                                                                                                      complexed SMN, inaccessible                                                                                                      Mib1 unlikely ubiquitinated <br />                                                                                                      degraded. <br /> FIGURE 3:&#226;&#8364;&#8218;   HEK-293T cells transfected 100 pmol scrambled siRNA                article preparation, <br /> Mib1 siRNA 72 h. Mib1 SMN protein levels determined 72 h Western <br />                                                                                                      Usp9x  known fat facets, FAM), blotting. (B) HEK-293T cells transfected 100 &#206;&#188;M negative control miRNA                                                                                                      deubiquitinating enzyme (DUB), miR-137 72 h. SMN protein levels determined Western blotting. data represent mean &#194;&#177; SEM independent experiments. (C) SMA patient&#226;&#8364;&#8220;derived fibroblasts (3813)          stabilize SMN reducing ubiquitina- transfected Mib1 siRNA scrambled control. Cells harvested 72 h post-               tion (Han et&#194;&#160;al., 2012). Interestingly, Usp9x/ <br /> transfection, Mib-1 mRNA SMN protein levels assessed RT-PCR Western              FAM interacts Mib1 (Choe et&#194;&#160; al., <br /> blot analysis, respectively. (D) HEK-293T cells transfected Mib1 siRNA, miR-137,        2007), points possibility scrambled control. Cells harvested 72 h posttransfection, SMN mRNA level                Usp9x Mib1 act concert regulate <br /> analyzed RT-PCR. *, p &lt; 0.05; **, p &lt; 0.01; ***, p &lt; 0.001.                                       SMN protein levels. <br />                                                                                                          genetic modifiers SMA siRNAs microRNA mir-137 stabilizes SMN. data           reported humans: SMN2 plastin3. genome-wide RNAi <br /> demonstrate Mib1-mediated ubiquitination SMN enhances               screen C. elegans Drosophila deficient SMN identified degradation decreases steady-state SMN protein levels.              genes modify disease phenotype model sys- <br />     SMA patients homozygous deletion                 tems (Dimitriadi et&#194;&#160;al., 2010). SMN deficiency C. elegans char- <br /> SMN1 gene, retain copy SMN2. major             acterized marked reduction rate pharyngeal pumping. <br /> SMN2 gene product truncated SMN&#206;&#8221;7 protein  based             Mib1 knockdown RNAi partially rescues ability extend survival SMA mice, likely retains         SMN-deficient phenotype C. elegans, indicating Mib1 function unstable rapidly degraded. instability           modifier SMA. biochemical data suggest Mib1 pro- <br /> SMN&#206;&#8221;7 thought number factors, including            motes SMN degradation proteasome.  inability self-associate (Lorson et&#194;&#160;al., 1998; Burnett et&#194;&#160;al., 2009)     rule possibility SMN-independent pathways involving presence degradation signal promotes rapid            functions Mib1 responsible partial rescue turnover (Cho Dreyfuss, 2010). study, Mib1         neuromuscular phenotype. Nonetheless, identification new <br />  <br />  <br /> Volume 24&#226;&#8364;&#402; June 15, 2013	                                                                                Mib1 targets SMN degradation&#226;&#8364;&#402; |&#226;&#8364;&#402; 1867&#226;&#8364;&#402; <br />                                                                                                modifier SMA phenotype partic- <br />                                                                                               ular importance, given currently limited <br />                                                                                               number targets favorable thera- <br />                                                                                               peutic index. <br />                                                                                                   steady-state level protein                                                                                               governed balance protein <br />                                                                                               synthesis degradation. Strategies  <br />                                                                                               crease SMN protein synthesis regulat- <br />                                                                                               ing gene, stabilizing mRNA, al- <br />                                                                                               tering splicing promote inclusion exon <br />                                                                                               7 pursued SMA therapeutic <br />                                                                                               development. SMN2 gene pro- <br />                                                                                               duces length SMN protein sug- <br />                                                                                               gests strategies slow degradation <br />                                                                                               therapeutic options.                                                                                               SMN ubiquitinated degraded                                                                                               proteasome, retarding turnover                                                                                               blocking proteasome inhibit- <br />                                                                                               ing SMN ubiquitination useful                                                                                               treating SMA. shown SMA <br />                                                                                               mice treated proteasome inhibitor <br />                                                                                               bortezomib reduced pathology                                                                                               improved motor function (Kwon et&#194;&#160;al., 2011). <br />                                                                                                toxicity available protea- <br />                                                                                               inhibitors preclude chronic use                                                                                               SMA patients. small molecule inhibi- <br />                                                                                               tors proteasome devel- <br />                                                                                               oped research clinical use, E3 ubiq- <br />                                                                                               uitin ligases emerging targets                                                                                               disease treatment, confer                                                                                               substrate specificity UPS. Drugs                                                                                               inhibit E3 ligases involved cell cycle regu- <br />                                                                                               lation cell proliferation currently  <br />                                                                                               der study treat various types cancer. <br />                                                                                               E3 ligase, murine double minute 2 <br />                                                                                               (MDM2), regulates tumor suppressor <br />                                                                                               p53 represses role cell cycle arrest <br />                                                                                               apoptosis (Fakharzadeh et&#194;&#160; al., 1993; <br />                                                                                               Haupt et&#194;&#160;al., 1997). Inhibitors human <br />                                                                                               homologue MDM2 shown FIGURE 4:&#226;&#8364;&#8218;   Endogenous SMN immunoprecipitated HEK-293T cell lysates       reduce tumor growth induce tumor cell <br /> antibody SMN, immunoprecipitates resolved SDS&#226;&#8364;&#8220;PAGE. Association           apoptosis vitro, providing incentive Mib1 determined Western blot analysis using antibody Mib1. (B) Protein lysates   targeting MDM2 function treat cancer HEK-293T cells immunoprecipitated SMN antibody. Mib1                  vivo (Issaeva et&#194;&#160; al., 2004; Koblish et&#194;&#160; al., <br /> coimmunoprecipitated SMN, Mib2 detected Western blot analysis.                2006). High-throughput small molecule <br /> Membranes probed anti-SMN, anti-Mib1, anti-Mib2 antibodies. (C) GST                                                                                               compound screens used iden- <br /> GST-SMN used pull purified recombinant Mib1 protein. (D) Myc-tagged Mib1 <br />                                                                                               tify inhibitors E3 ligases (Davydov et&#194;&#160; al., <br /> constructs containing length truncated transcripts Mib1 gene transiently transfected HEK-293T cells. Immunoprecipitation using anti-myc antibody   2004; Huang et&#194;&#160; al., 2005). screens performed, interaction endogenous SMN detected Western blot analysis      adapted identify molecules using anti-SMN antibody. (E) HEK-293T cells transfected 0.5 &#206;&#188;g length SMN   disrupt interaction ligase cDNA various SMN constructs single-exon deletion, 2 &#206;&#188;g Mib1-FLAG. Mib1-         protein substrate, confer <br /> FLAG immunoprecipitated resolved SDS&#226;&#8364;&#8220;PAGE gel. Western blots probed         greater selectivity reduce target ef- antibodies FLAG Myc determine binding Mib1 SMN. (F) HEK-293T cells       fects. Nutlin, inhibits interaction transfected 2 &#206;&#188;g Mib1-FLAG, 1 &#206;&#188;g HA-Ub, 1 &#206;&#188;g length SMN-myc      MDM2 p53, identified SMN&#206;&#8221;6-myc. cells harvested 48 h later, myc-tagged SMN immunoprecipitated         small molecule screen (Vassilev et&#194;&#160;al., 2004) <br /> using anti-myc antibody, proteins separated SDS&#226;&#8364;&#8220;PAGE detected                                                                                               currently evaluated early- <br /> Western blotting. blots probed HA antibody detect ubiquitinated SMN. <br />                                                                                               phase clinical trials. new, toxic, <br /> (G) HEK-293T cells transfected 2 &#206;&#188;g Mib1-myc 0.5 &#206;&#188;g GFP-tagged <br /> wild-type SMN, SMN G279V, SMN Y272C. cells harvested 48 h later, SMN          general proteasome inhibitors  immunoprecipitated anti-myc antibody resolved SDS&#226;&#8364;&#8220;PAGE gel. Western      veloped, targeting E3 ligase selec- <br /> blots probed antibodies myc GFP determine interaction Mib1         tively tags SMN degradation wild-type SMN disease-associated mutants.                                              safer effective. Small molecule <br />  <br />  <br />  <br /> 1868&#226;&#8364;&#402; |&#226;&#8364;&#402; D. Y. Kwon et al.	                                                                                      Molecular Biology Cell <br />                                                                                                   (Sigma-Aldrich, St. Louis, MO) used                                                                                                  1:1000 dilution; anti-FLAG M2 (Sigma- <br />                                                                                                  Aldrich), anti-Myc 9E10 (Santa Cruz Biotech- <br />                                                                                                  nology, Santa Cruz, CA), anti-HA (Sigma- <br />                                                                                                  Aldrich), anti-actin (Sigma-Aldrich)                                                                                                  used 1:5000 dilution. Anti-Mib1 serum <br />                                                                                                  gift Junmin Peng (St. Jude <br />                                                                                                  Children&#226;&#8364;&#8482;s Research Hospital). signal <br />                                                                                                  visualized secondary antibody <br />                                                                                                  (anti-mouse anti-rabbit immunoglobulin- <br />                                                                                                  horseradish peroxidase, 1:3000&#226;&#8364;&#8220; <br />                                                                                                  10,000 dilution) using chemiluminescence <br />                                                                                                  detection (Perkin Elmer-Cetus, <br /> FIGURE 5:&#226;&#8364;&#8218;   HEK-293T cells transfected 2 &#206;&#188;g length SMN SMN&#206;&#8221;7            Waltham, MA). <br /> 1 &#206;&#188;g Mib1-FLAG HA-Ub cDNAs. cells harvested 48 h later, SMN                         immunoprecipitation experiments, <br /> immunoprecipitated resolved SDS&#226;&#8364;&#8220;PAGE, proteins analyzed Western           cell lysates clarified centrifugation <br /> blotting. blots probed HA antibody detect ubiquitinated SMN.                 precleared pan-mouse immuno- <br /> (B) Pulse&#226;&#8364;&#8220;chase analysis length SMN SMN&#206;&#8221;7, absence presence 2 &#206;&#188;g        globulin G (IgG) Dynabeads (Invitrogen) Mib1-myc. data represent mean &#194;&#177; SEM experiments.                                1 h 4&#194;&#176;C. lysates incubated <br />                                                                                                  1 &#206;&#188;g antibody 2 h overnight <br /> screens identify inhibitors Mib1 lead novel thera-     incubated pan-mouse IgG Dynabeads 1 h peutics SMA.                                                         rotator 4&#194;&#176;C. beads washed NP-40 buffer                                                                          times boiled SDS gel-loading buffer. Eluted proteins <br /> MATERIALS METHODS                                                    run SDS&#226;&#8364;&#8220;PAGE Western blotting. <br /> Plasmids miRNA                                                           pull assay, 5 &#206;&#188;g purified recombinant Mib1 protein <br /> Plasmids encoding human length truncated Mib1              purchased Origene (Rockville, MD; TP321377) incubated <br /> constructed previously described (Itoh et&#194;&#160;al., 2003). Mib1 shRNA      GST SMN-GST beads 4&#194;&#176;C rotator overnight. Samples nonsilencing control purchased SABiosciences               spun  beads washed times NP-40 <br /> (KM26177G) pre-miR miRNA precursors (control miR-137)            buffer. Following wash, beads boiled SDS gel- purchased Ambion (PM10513). Myc-Parkin obtained            loading buffer 5 min, eluted proteins processed Chitnis lab.                                                    Western blotting. <br />  <br /> Cell culture, transfection, Western blotting                          RNA extraction quantification <br /> Human embryonic kidney HEK-293T NSC34 cells main-                Cells homogenized 500 &#206;&#188;l TRIzol reagent (Invitrogen) tained 37&#194;&#176;C 5% <span id='am-1' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-2' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="CO2" datatype="xsd:string"></span>CO2</span> DMEM (Invitrogen, Carlsbad, CA)             spun 10 min 4&#194;&#176;C. microliters chloroform supplemented 10% FBS penicillin/streptomycin/glutamine           added supernatant, mixture vortexed spun <br /> (Invitrogen). Cells plated culture plate tran-    aqueous upper phase transferred  <br /> siently transfected 0.5&#226;&#8364;&#8220;4 &#206;&#188;g plasmid DNA using           tube, 250 &#206;&#188;l isopropanol 50 &#206;&#188;l 3M sodium acetate FuGENE HD transfection reagent (Roche Applied Science, India-             added. RNA pelleted, washed 70% ethanol, <br /> napolis,  according manufacturer&#226;&#8364;&#8482;s protocol. total          resuspended 100 &#206;&#188;l DNase- RNase-free water. Total DNA used transfection kept constant             RNA quantified absorption 260 nm, 450 ng experiment adding appropriate vector                RNA sample converted cDNA using High Capacity <br /> plasmid. Cells harvested 24&#226;&#8364;&#8220;48 h posttransfection.                   cDNA Reverse Transcription kit (Applied Biosystems, Bedford, MA). <br />     siRNA miRNA transfections, HEK-293T cells                Aliquots 20 &#206;&#188;l quantitative PCRs run triplicate using plated subconfluently culture dish transfected          ABI Prism 7900 sequence detection (Applied Biosystems). 100 pmol siRNA/miRNA 10 &#206;&#188;l Lipofectamine 2000              levels <span id='am-37' about='obo:IMR_0200173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-38' property="oboInOwl:id" content="IMR:0200173" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="KEGG:C00262" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="Hypoxanthine" datatype="xsd:string"></span>hypoxanthine</span> phosphoribosyltransferase (HPRT; <br /> (Invitrogen). 48 h transfection, cells transfected    control), SMN, Mib1 transcripts quantified thresh- siRNA/miRNA 24 h harvested total 72 h        old cycle primers purchased Applied Biosystems. <br /> transfection. <br />                                                                           Immunohistochemical analysis gem numbers <br /> Western blotting, immunoprecipitation,                                    gem number assayed 24 h transfection myc-Mib1 pull assays                                                      myc-Mib1-C1009S. cells fixed, permeabilized, im- <br /> Transfected cells lysed NP-40 lysis buffer (1% NP-40,      munostained anti-SMN anti-myc antibodies. Blinded counts <br /> 50 mM Tris-HCl, 150 mM NaCl, pH 8.0) RIPA buffer (1% Triton            gems performed 300 nuclei condition. <br /> X-100, 1% sodium deoxycholate, 150 mM NaCl, 0.1% SDS, pH 8.0) quantified using BCA Protein Assay Kit (Pierce, Rockford,      vitro ubiquitination Western blotting. Equal amounts protein lysate (15 &#206;&#188;g)        Recombinant SMN protein (Enzo Life Sciences, Farmingdale, NY) <br /> run separated 10% SDS&#226;&#8364;&#8220;PAGE (Invitrogen) transferred          incubated ubiquitin, E1 ubiquitin-activating enzyme polyvinylidene fluoride membrane (Invitrogen).             (Boston Biochem, Cambridge, MA), E2 ubiquitin-conjugating probed appropriate antibodies 5% milk washed         enzyme, UBCH5B, recombinant Mib1 (OriGene Technologies, Tris-buffered saline Tween 20. Antibodies: anti-SMN (BD          Rockville, MD) reaction buffer (50 mM Tris-HCl, pH 7.5, 2 mM <span id='am-18' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-19' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>ATP</span>, <br /> Transduction), anti-Mib1 (Epitomics, Burlingame, CA), anti-Mib2       4 mM MgCl2, 2 mM dithiothreitol [DTT]) 1 h 37&#194;&#176;C. Reactions <br />  <br />  <br /> Volume 24&#226;&#8364;&#402; June 15, 2013	                                                                            Mib1 targets SMN degradation&#226;&#8364;&#402; |&#226;&#8364;&#402; 1869&#226;&#8364;&#402; <br />                                                                                                          Construction RNAi feeding clone                                                                                                         Y47D3A.22/mib-1 <br />                                                                                                         796&#226;&#8364;&#8220;base pair PCR product correspond- <br />                                                                                                         ing C. elegans mib-1 cDNA (Berndt <br />                                                                                                         et&#194;&#160;al., 2011) cloned L4440 RNAi <br />                                                                                                         feeding vector; followed                                                                                                         transformation HT115(DE3) bacte- <br />                                                                                                         rial strain (Timmons  1998; <br />                                                                                                         Timmons et&#194;&#160;al., 2001). Primers amplifica- <br />                                                                                                         tion ACH72 5&#226;&#8364;&#8482;-tgatgctagcgcagcttctc- <br />                                                                                                         ctgttgcgtg-3&#226;&#8364;&#8482; ACH73 5&#226;&#8364;&#8482;-tgatctcga&#194;&#173;ggcg&#194;&#173; <br />                                                                                                         ggagccga&#194;&#173;tttgaactg-3&#226;&#8364;&#8482;. <br />  <br />                                                                                                         C. elegans pharyngeal pumping assay <br />                                                                                                       pharyngeal pumping assay  <br />                                                                                                       formed previously described (Dimitriadi <br />                                                                                                       et&#194;&#160;al., 2010). Briefly, eggs hatched L4440 <br />                                                                                                       control       vector     (L4440     [RNAi])                                                                                                            (Y47D3A.22/mib-1[RNAi]) bacterial feeding <br />                                                                                                       strains (Kamath Ahringer, 2003) FIGURE 6:&#226;&#8364;&#8218; Knockdown C. elegans orthologue Mib1 ameliorates pharyngeal <br /> pumping neuromuscular defects smn-1 loss function animals.   mib-1 knockdown                  reared 2 d 25&#194;&#176;C 1 d 20&#194;&#176;C. <br /> significantly increases pharyngeal pumping smn-1 deficient animals SID-1 sensitization,       Pumping rates determined using increases RNAi neuronal sensitivity. (B) Loss Notch coligand function smn-1           AxioCam ICc1 camera Zeiss Stemi SV11 <br /> mutants did ameliorate pharyngeal pumping defect smn-1(ok355);osm-11(rt142)                microscope (Carl Zeiss, Jena, Germany). animals. Pharyngeal pumping events measured control mib-1 RNAi-fed                   pumping event scored pharyngeal <br /> animals. error bars SEM; *, p &lt; 0.05.                                                         grinder movement axis, average <br />                                                                                                       pumping rates (&#194;&#177; SEM) derived quenched 30 &#206;&#188;l 5&#195;&#8212; Laemmli sample buffer (200 mM Tris,          blinded manner independent trials (n &#226;&#8240;&#165; 30 ani- <br /> pH 6.8, 32% [vol/vol] glycerol, 6.4% [wt/vol] SDS, 0.32% [wt/vol] bro-      mals total). Heterozygous homozygous smn-1 loss function <br /> mophenol blue, 200 mM DTT), boiled 5 min, separated             animals distinguished green fluorescent protein (GFP) fluo- SDS&#226;&#8364;&#8220;PAGE. SMN ubiquitination analyzed Western blot-              rescence. wild-type (N2) smn-1 loss function heterozy- <br /> ting, using antibody polyubiquitin (FK1; Enzo Life Sciences).       gous animals showed pumping rates significantly dif- <br />                                                                             ferent.  heterozygous smn-1 loss function animals Pulse&#226;&#8364;&#8220;chase protein labeling                                                used controls study. <br /> Pulse&#226;&#8364;&#8220;chase analysis performed previously described (Burnett <br /> et&#194;&#160; al., 2009). brief, HEK-293T cells incubated cysteine-        Statistics <br /> methionine&#226;&#8364;&#8220;free medium (Sigma-Aldrich) 2 h 12 h;            biochemical data analyzed GraphPad Prism <br /> followed incubation cysteine-methionine&#226;&#8364;&#8220;free medium contain-          software package (GraphPad Software, San Diego, CA) com- <br /> ing 100 &#206;&#188;Ci [35S]-labeled cysteine-methionine (GE Healthcare,            pared statistically t test way analysis variance, <br /> Piscataway, NJ) 1 h. labeling, cells washed         Newman-Keuls multiple-comparison post hoc correction. culture medium containing 10-fold excess unlabeled methi-         compare differences groups, performed onine cysteine (5 mM  incubated            nonparametric equality medians test, data medium. cells collected indicated time points          normally distributed. statistically significant, processed immunoprecipitation anti-SMN antibody (BD            pairwise comparison treatment groups Transduction Laboratories). Immunoprecipitations carried           using Mann-Whitney test. 6 h 4&#194;&#176;C antibodies bound protein G-Sepharose (Sigma- <br /> Aldrich). washes lysis buffer (100 mM NaCl, 10 mM          ACKNOWLEDGMENTS <br /> Tris-HCl, pH 7.4, 2.5 mM MgCl2, 0.1% NP-40, protease [Roche])           thank Liu Yang (University Arkansas) myc-tagged phosphatase inhibitor cocktails (Sigma-Aldrich), bound proteins         FL-SMN deletion mutant cDNAs. work supported eluted boiling SDS&#226;&#8364;&#8220;PAGE sample buffer. Immunocom-                intramural research funds National Institute Neurological <br /> plexes separated 10% SDS&#226;&#8364;&#8220;PAGE. gels dried              Disorders Stroke National Institutes Health&#226;&#8364;&#8220;National <br /> exposed phosphorimager screen, signal visualized           Institute Neurological Disorders Stroke (NS066888) C.H. Storm phosphorimager (Molecular Dynamics, Piscat- <br /> away, NJ). Densitometric analysis protein bands carried      REFERENCES <br />                                                                             Barsi JC, Rajendra R, Wu JI, Artzt K (2005). Mind bomb1 ubiquitin ligase <br /> using ImageQuant PhosphorImager software (Molecular Dynamics). <br />                                                                                   essential mouse embryonic development Notch signaling. Mech <br />                                                                                   Dev 122, 1106&#226;&#8364;&#8220;1117. <br /> C. elegans strains                                                            Berndt JD, Aoyagi  Yang P, Anastas JN, Tang L, Moon RT (2011). Mind- <br /> TU3311 uIs60 [unc-119p::yfp, unc-119p::sid-1] (Calixto et&#194;&#160;al., 2010),             bomb 1, E3 ubiquitin ligase, forms complex RYK activate <br /> HA2258 smn-1(ok355)/hT2[bli-4(e937) let-?(q782) qIs48]  III); uIs60             Wnt/&#206;&#178;-catenin signaling. J Cell Biol 194, 737&#226;&#8364;&#8220;750. <br />                                                                               Brenner S (1974). genetics Caenorhabditis elegans. Genetics 77, <br /> (Briese et&#194;&#160;al., 2009), HA2201 smn-1(ok355)/hT2[bli-4(e937) let-               71&#226;&#8364;&#8220;94. <br /> ?(q782) qIs48]  III); osm-11(rt142)X maintained 20&#194;&#176;C ac-            Briese M, Esmaeili B, Fraboulet S, Burt EC, Christodoulou S, Towers PR, <br /> cording standard protocols (Brenner, 1974).                                    Davies KE, Sattelle DB (2009). Deletion smn-1, Caenorhabditis <br />  <br />  <br /> 1870&#226;&#8364;&#402; |&#226;&#8364;&#402; D. Y. Kwon et al.	                                                                                                 Molecular Biology Cell <br />      elegans ortholog spinal muscular atrophy gene, results locomo-      Kwon DY, Motley WW, Fischbeck KH, Burnett BG (2011). Increasing expres- <br />     tor dysfunction reduced lifespan. Hum Mol Genet 18, 97&#226;&#8364;&#8220;104.                   sion decreasing degradation SMN ameliorate spinal muscular <br /> Burnett BG, Munoz E, Tandon  Kwon DY, Sumner CJ, Fischbeck KH                       atrophy phenotype mice. Hum Mol Genet 20, 3667&#226;&#8364;&#8220;3677. <br />     (2009). Regulation SMN protein stability. Mol Cell Biol 29, 1107&#226;&#8364;&#8220;1115.     Lai EC, Roegiers F, Qin X, Jan YN, Rubin GM (2005). ubiquitin ligase <br /> Calixto  Chelur D, Topalidou  Chen X, Chalfie M (2010). Enhanced neu-             Drosophila Mind bomb promotes Notch signaling regulating     ronal RNAi C. elegans using SID-1. Nat Methods 7, 554&#226;&#8364;&#8220;559.                     localization activity Serrate Delta. Development 132, <br /> Chang HC et&#194;&#160;al. (2008). Modeling spinal muscular atrophy Drosophila.               2319&#226;&#8364;&#8220;2332. <br />     PLoS 3, e3209.                                                            Le TT, Pham LT, Butchbach  Zhang HL, Monani UR, Coovert DD, <br /> Chang HC, Hung WC, Chuang YJ, Jong YJ (2004). Degradation survival                 Gavrilina  Xing L, Bassell GJ, Burghes AH (2005). SMNDelta7,     motor neuron (SMN) protein mediated ubiquitin/proteasome               major product centromeric survival motor neuron (SMN2) gene, <br />     pathway. Neurochem Int 45, 1107&#226;&#8364;&#8220;1112.                                             extends survival mice spinal muscular atrophy associates <br /> Chen W, Casey Corliss D (2004). modules zebrafish Mind bomb                  length SMN. Hum Mol Genet 14, 845&#226;&#8364;&#8220;857. <br />     work cooperatively promote Delta ubiquitination endocytosis.           Le Borgne R, Remaud S, Hamel S, Schweisguth F (2005). distinct E3 <br />     Dev Biol 267, 361&#226;&#8364;&#8220;373.                                                            ubiquitin ligases complementary functions regulation Cho S, Dreyfuss G (2010). degron created SMN2 exon 7 skipping               delta serrate signaling Drosophila. PLoS Biol 3, e96. <br />     principal contributor spinal muscular atrophy severity. Genes Dev 24,      Lefebvre S et&#194;&#160;al. (1995). Identification characterization spinal <br />     438&#226;&#8364;&#8220;442.                                                                          muscular atrophy-determining gene. Cell 80, 155&#226;&#8364;&#8220;165. <br /> Choe EA, Liao L, Zhou JY, Cheng D, Duong DM, Jin P, Tsai LH, Peng J               Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich  Dreyfuss <br />     (2007). Neuronal morphogenesis regulated interplay              G, Melki J (1997). Correlation severity SMN protein level     cyclin-dependent kinase 5 ubiquitin ligase mind bomb 1.                   spinal muscular atrophy. Nat Genet 16, 265&#226;&#8364;&#8220;269. <br />     J Neurosci 27, 9503&#226;&#8364;&#8220;9512.                                                     Lorson CL, Androphy EJ (2000). exonic enhancer required inclusion <br /> Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford  Mendell                  essential exon SMA-determining gene SMN. Hum Mol <br />     JR, Coulson SE, Androphy EJ, Prior TW, Burghes AH (1997). survival            Genet 9, 259&#226;&#8364;&#8220;265. <br />     motor neuron protein spinal muscular atrophy. Hum Mol Genet 6,             Lorson CL, Hahnen E, Androphy EJ, Wirth B (1999). single <span id='am-29' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-30' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-33' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span>     1205&#226;&#8364;&#8220;1214.                                                                        SMN gene regulates splicing responsible spinal muscular <br /> Davydov IV, Woods D, Safiran YJ, Oberoi P, Fearnhead HO, Fang S, Jensen               atrophy. Proc Natl Acad Sci USA 96, 6307&#226;&#8364;&#8220;6311. <br />     JP, Weissman  Kenten JH, Vousden KH (2004). Assay ubiquitin            Lorson CL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, Le T, <br />     ligase activity: high-throughput screen inhibitors HDM2. J Biomol          Burghes AH, Androphy EJ (1998). SMN oligomerization defect corre- <br />     Screen 9, 695&#226;&#8364;&#8220;703.                                                                lates spinal muscular atrophy severity. Nat Genet 19, 63&#226;&#8364;&#8220;66. <br /> Dimitriadi M et&#194;&#160;al. (2010). Conserved genes act modifiers invertebrate      McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, <br />     SMN loss function defects. PLoS Genet 6, e1001172.                             Prior TW, Burghes AH (1997). Identification proximal spinal muscular <br /> Fakharzadeh SS, Rosenblum-Vos L, Murphy M, Hoffman EK, George DL                      atrophy carriers patients analysis SMNT SMNC gene copy <br />     (1993). Structure organization amplified DNA double minutes             number. J Hum Genet 60, 1411&#226;&#8364;&#8220;1422. <br />     containing mdm2 oncogene. Genomics 15, 283&#226;&#8364;&#8220;290.                           McWhorter ML, Monani UR, Burghes AH, Beattie CE (2003). Knockdown Han KJ, Foster DG, Zhang NY, Kanisha K, Dzieciatkowska M, Sclafani RA,                survival motor neuron (Smn) protein zebrafish causes defects     Hansen KC, Peng J, Liu CW (2012). Ubiquitin-specific protease 9x deu-             motor axon outgrowth pathfinding. J Cell Biol 162, 919&#226;&#8364;&#8220;931. <br />     biquitinates stabilizes spinal muscular atrophy protein&#226;&#8364;&#8221;survival      Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, <br />     motor neuron. J Biol Chem 287, 43741&#226;&#8364;&#8220;43752.                                       McPherson JD (1999). single nucleotide difference alters splicing <br /> Haupt Y, Maya R, Kazaz  Oren M (1997). Mdm2 promotes rapid deg-                 patterns distinguishes SMA gene SMN1 copy gene SMN2. <br />     radation p53. Nature 387, 296&#226;&#8364;&#8220;299.                                             Hum Mol Genet 8, 1177&#226;&#8364;&#8220;1183. <br /> Hsieh-Li HM, Chang JG, Jong YJ, Wu MH, Wang NM, Tsai CH, Li H (2000).             Pellizzoni L, Charroux B, Dreyfuss G (1999). SMN mutants spinal muscular <br />     mouse model spinal muscular atrophy. Nat Genet 24, 66&#226;&#8364;&#8220;70.                   atrophy patients defective binding snRNP proteins. Proc Natl <br /> Huang J, Sheung J, Dong G, Coquilla C, Daniel-Issakani S, Payan DG                    Acad Sci USA 96, 11167&#226;&#8364;&#8220;11172. <br />     (2005). High-throughput screening inhibitors e3 ubiquitin          Petroski MD (2008). ubiquitin  disease, drug discovery. <br />     ligase APC. Methods Enzymol 399, 740&#226;&#8364;&#8220;754.                                         BMC Biochem 9, S7. <br /> Issaeva N, Bozko P, Enge M, Protopopova M, Verhoef LG, Masucci M,                 Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ (2004). Homozygous <br />     Pramanik  Selivanova G (2004). Small molecule RITA binds p53,                SMN1 deletions unaffected family members modification     blocks p53-HDM-2 interaction activates p53 function tumors.                phenotype SMN2. J Med Genet 130, 307&#226;&#8364;&#8220;310. <br />     Nat Med 10, 1321&#226;&#8364;&#8220;1328.                                                        Rual JF et&#194;&#160;al. (2004). improving Caenorhabditis elegans phenome <br /> Itoh M et&#194;&#160;al. (2003). Mind bomb ubiquitin ligase essential           mapping ORFeome-based RNAi library. Genome Res 14, <br />     efficient activation Notch signaling Delta. Dev Cell 4, 67&#226;&#8364;&#8220;82.              2162&#226;&#8364;&#8220;2168. <br /> Jarecki J, Chen X, Bernardino  Coovert DD, Whitney M, Burghes                 Singh K et&#194;&#160;al. (2011). C. elegans Notch signaling regulates adult chemosen- <br />     Stack J, Pollok BA (2005). Diverse small-molecule modulators SMN               sory response larval molting quiescence. Curr Biol 21, 825&#226;&#8364;&#8220;834. <br />     expression high-throughput compound screening: early leads           Smrt RD et&#194;&#160;al. (2010). MicroRNA miR-137 regulates neuronal maturation     therapeutic spinal muscular atrophy. Hum Mol Genet 14,              targeting ubiquitin ligase mind bomb-1. Stem Cells 28, 1060&#226;&#8364;&#8220;1070. <br />     2003&#226;&#8364;&#8220;2018.                                                                    Timmons L, Court DL, (2001). Ingestion bacterially expressed <br /> Jin Y, Blue EK, Dixon S, Shao  Gallagher PJ (2002). death-associated              dsRNAs produce specific potent genetic interference     protein kinase (DAPK)-interacting protein, DIP-1, E3 ubiquitin ligase       Caenorhabditis elegans. Gene 263, 103&#226;&#8364;&#8220;112. <br />     promotes tumor necrosis factor-induced apoptosis regulates           Timmons L, (1998). Specific interference ingested dsRNA. Nature <br />     cellular levels DAPK. J Biol Chem 277, 46980&#226;&#8364;&#8220;46986.                        395, 854. <br /> Kamath RS, Ahringer J (2003). Genome-wide RNAi screening Caenorhab-            Vassilev LT et&#194;&#160;al. (2004). vivo activation p53 pathway small- <br />     ditis elegans. Methods 30, 313&#226;&#8364;&#8220;321.                                               molecule antagonists MDM2. Science 303, 844&#226;&#8364;&#8220;848. <br /> Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J (2001).          Wolstencroft EC, Mattis V, Bajer AA, Young PJ, Lorson CL (2005). non- <br />     Effectiveness specific RNA-mediated interference ingested              sequence-specific requirement SMN protein activity: role     double-stranded RNA Caenorhabditis elegans. Genome Biol 2,                     aminoglycosides inducing elevated SMN protein levels. Hum Mol <br />     RESEARCH0002.                                                                     Genet 14, 1199&#226;&#8364;&#8220;1210. <br /> Koblish HK et&#194;&#160;al. (2006). Benzodiazepinedione inhibitors Hdm2:p53          Yoo KW, Kim EH, Jung SH, Rhee M, Koo BK, Yoon KJ, Kong YY, Kim CH <br />     complex suppress human tumor cell proliferation vitro sensitize            (2006). Snx5, Mind bomb-binding protein, expressed  <br />     tumors doxorubicin vivo. Mol Cancer Ther 5, 160&#226;&#8364;&#8220;169.                        matopoietic endothelial precursor cells zebrafish. FEBS Lett 580, <br /> Komatsu H et&#194;&#160;al. (2008). OSM-11 facilitates LIN-12 Notch signaling             4409&#226;&#8364;&#8220;4416. <br />     Caenorhabditis elegans vulval development. PLoS Biol 6, e196.                 Zhang C, Li Q, Jiang YJ (2007). Zebrafish Mib Mib2 mutual E3 <br /> Koo BK et&#194;&#160;al. (2005a). Mind bomb 1 essential generating functional             ubiquitin ligases common specific delta substrates. J Mol Biol <br />      <br /> </body></html>